In patients with hepatitis B and co-infection with hepatitis D, given their increased risk of development of HCC, how do you approach screening for this?

Screening frequency is based on tumor-doubling size and not risk of HCC. Every 6 months, imaging is recommended + AFP. HDV patients should be screened if advanced fibrosis (F3-4) is present or VCTE > 9 kPA.